TrialPloS one2018
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma.
Heather L Gardner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
TrialPloS one2018
Heather L Gardner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.